SMS Pharmaceuticals Limited — Important, 12-02-2025: Updates

The Board of Directors of SMS Pharmaceuticals Limited has approved the updated Code for Regulation and Prohibition of Insider Trading. This revised code, now in effect, aims to enhance transparency and compliance in handling unpublished price-sensitive information (UPSI). Key amendments focus on defining guidelines for insider trading, ensuring confidentiality, and delineating responsibilities for compliance. Furthermore, it stipulates procedures for trading during designated windows and specifies protocols for addressing any leaks or suspected leaks of UPSI. This move is expected to reinforce governance standards and uphold the integrity of trading practices in the company’s securities. Investors should view this development positively as it aligns with best practices for corporate governance and market fairness.